Biotech Ag Bb, 10% Owner at Esperion Therapeutics, Inc. (ESPR), bought 200,000 shares at $20.37 ($4.1M) on 2021-05-19, disclosed to the SEC on 2021-05-21.
Open-market purchase of $4.1M ESPR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| MGNX | BUY | 2023-10-04 | $669K | — | Filing → |
| MTEM | BUY | 2023-07-19 | $4.0M | — | Filing → |
| BDTX | BUY | 2023-07-03 | $5.0M | — | Filing → |